RAPP Rapport Therapeutics
- 21.110
- +0.300+1.44%
- 20.200
- -0.910-4.31%
Rapport Therapeutics News
Rapport Therapeutics | 10-Q: Quarterly report
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | SEC STAFF LETTER: Others
Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(13.624%),Abigail P. Johnson(13.624%)
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES
Rapport Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(3.5 %),GOLDMAN SACHS & CO. LLC(3.5 %), etc.
Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(7.5 %),GOLDMAN SACHS & CO. LLC(7.5 %), etc.
Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%), etc.
Rapport Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%), etc.
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners XII, LLC
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Galer Bradley S.
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gault Cheryl
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bredt David
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yeleswaram Krishnaswamy
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Third Rock Ventures V, L.P.
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ceesay Abraham
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES
Rapport Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ignelzi Troy A.
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
